{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:30:56Z","timestamp":1784413856392,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent studies revealed that alterations in glucose and lipid metabolism in idiopathic pulmonary arterial hypertension (IPAH) are associated with disease severity and poor survival. However, data regarding the impact of diabetes mellitus (DM) on the prognosis of patients with IPAH remain scarce. The aim of our study was to determine that impact using data from a national multicentre prospective pulmonary hypertension registry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed data of adult patients with IPAH from the Database of Pulmonary Hypertension in the Polish population (BNP\u2011PL) between March 1, 2018 and August 31, 2020. Upon admission, clinical, echocardiographic, and haemodynamic data were collected at 21 Polish IPAH reference centres. The all-cause mortality was assessed during a 30-month follow-up period. To adjust for differences in age, body mass index (BMI), and comorbidities between patients with and without DM, a 2-group propensity score matching was performed using a 1:1 pairing algorithm.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 532 patients with IPAH were included in the study and 25.6% were diagnosed with DM. Further matched analysis was performed in 136 patients with DM and 136 without DM. DM was associated with older age, higher BMI, more advanced exertional dyspnea, increased levels of N-terminal pro\u2013brain natriuretic peptide, larger right atrial area, increased mean right atrial pressure, mean pulmonary artery pressure, pulmonary vascular resistance, and all-cause mortality compared with no DM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with IPAH and DM present with more advanced pulmonary vascular disease and worse survival than counterparts without DM independently of age, BMI, and cardiovascular comorbidities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01885-6","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T16:02:36Z","timestamp":1689264156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry\u00a0(BNP-PL)"],"prefix":"10.1186","volume":"22","author":[{"given":"Kamil","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kurzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Mroczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Chrzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Mularek-Kubzdela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Skoczylas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"B\u0142aszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Grze\u015bk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mizia-Stec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Lewicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Peregud-Pogorzelska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Jache\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ryczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Pruszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Doboszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Widejko-Pietkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142awa","family":"Zab\u0142ocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Walig\u00f3ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Kope\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"1885_CR1","doi-asserted-by":"publisher","unstructured":"Humbert M, Kovacs G, Hoeper MM, the European Respiratory Society (ERS). 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Developed by: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and. Endorsed by: the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2022;43(38):3618\u20133731. doi: https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","DOI":"10.1093\/eurheartj\/ehac237"},{"issue":"1","key":"1885_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the european respiratory society (ERS): endorsed by: Association for European Paediatric and congenital cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"issue":"9","key":"1885_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1164\/rccm.201002-0250OC","volume":"182","author":"TM Bull","year":"2010","unstructured":"Bull TM, Clark B, McFann K, Moss M, National Institutes of Health\/National Heart, Lung, and Blood Institute ARDS Network. Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. Am J Respir Crit Care Med. 2010;182(9):1123\u20138. https:\/\/doi.org\/10.1164\/rccm.201002-0250OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1885_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1183\/09031936.00000508","volume":"33","author":"RT Zamanian","year":"2009","unstructured":"Zamanian RT, Hansmann G, Snook S, et al. Insulin resistance in pulmonary arterial hypertension. Eur Respir J. 2009;33(2):318\u201324. https:\/\/doi.org\/10.1183\/09031936.00000508","journal-title":"Eur Respir J"},{"issue":"8","key":"1885_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.healun.2011.02.016","volume":"30","author":"ME Pugh","year":"2011","unstructured":"Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant. 2011;30(8):904\u201311. https:\/\/doi.org\/10.1016\/j.healun.2011.02.016","journal-title":"J Heart Lung Transplant"},{"key":"1885_CR6","doi-asserted-by":"publisher","first-page":"41650","DOI":"10.1038\/srep41650","volume":"7","author":"G Kope\u0107","year":"2017","unstructured":"Kope\u0107 G, Walig\u00f3ra M, Tyrka A, et al. Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension. Sci Rep. 2017;7:41650. https:\/\/doi.org\/10.1038\/srep41650. Published 2017 Feb 15.","journal-title":"Sci Rep"},{"issue":"6","key":"1885_CR7","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.5114\/aoms.2018.79242","volume":"15","author":"K Jonas","year":"2019","unstructured":"Jonas K, Walig\u00f3ra M, Mago\u0144 W, et al. Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension. Arch Med Sci. 2019;15(6):1397\u2013406. https:\/\/doi.org\/10.5114\/aoms.2018.79242","journal-title":"Arch Med Sci"},{"issue":"2","key":"1885_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1513\/AnnalsATS.201608-605OC","volume":"14","author":"GA Heresi","year":"2017","unstructured":"Heresi GA, Malin SK, Barnes JW, Tian L, Kirwan JP, Dweik RA. Abnormal glucose metabolism and high-energy expenditure in idiopathic pulmonary arterial hypertension. Ann Am Thorac Soc. 2017;14(2):190\u20139. https:\/\/doi.org\/10.1513\/AnnalsATS.201608-605OC","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"1885_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1183\/13993003.01700-2019","volume":"55","author":"JT Mey","year":"2020","unstructured":"Mey JT, Hari A, Axelrod CL, et al. Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study. Eur Respir J. 2020;55(4):190\u20139. https:\/\/doi.org\/10.1183\/13993003.01700-2019. Published 2020 Apr 9.","journal-title":"Eur Respir J"},{"issue":"5","key":"1885_CR10","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1172\/JCI32503","volume":"118","author":"G Hansmann","year":"2008","unstructured":"Hansmann G, de Jesus Perez VA, Alastalo TP, et al. An antiproliferative BMP-2\/PPARgamma\/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest. 2008;118(5):1846\u201357. https:\/\/doi.org\/10.1172\/JCI32503","journal-title":"J Clin Invest"},{"issue":"4","key":"1885_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1183\/09031936.00030312","volume":"41","author":"J West","year":"2013","unstructured":"West J, Niswender KD, Johnson JA, et al. A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J. 2013;41(4):861\u201371. https:\/\/doi.org\/10.1183\/09031936.00030312","journal-title":"Eur Respir J"},{"issue":"10","key":"1885_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.33963\/KP.14988","volume":"77","author":"G Kope\u0107","year":"2019","unstructured":"Kope\u0107 G, Kurzyna M, Mroczek E, et al. Database of Pulmonary Hypertension in the Polish Population (BNP\u2013PL): design of the registry [published correction appears in Kardiol Pol. 2019 Dec 19;77(12):1230]. Kardiol Pol. 2019;77(10):972\u20134. https:\/\/doi.org\/10.33963\/KP.14988","journal-title":"Kardiol Pol"},{"key":"1885_CR13","doi-asserted-by":"publisher","unstructured":"Kope\u0107 G, Kurzyna M, Mroczek E et al. Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med. 2020;9(1):173. Published 2020 Jan 8. doi:https:\/\/doi.org\/10.3390\/jcm9010173","DOI":"10.3390\/jcm9010173"},{"issue":"4","key":"1885_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229\u201334. https:\/\/doi.org\/10.1056\/NEJM199807233390404","journal-title":"N Engl J Med"},{"issue":"1","key":"1885_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12872-016-0422-0","volume":"16","author":"N Li","year":"2016","unstructured":"Li N, Yang YG, Chen MH. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016;16(1):238. https:\/\/doi.org\/10.1186\/s12872-016-0422-0. Published 2016 Nov 25.","journal-title":"BMC Cardiovasc Disord"},{"key":"1885_CR16","doi-asserted-by":"publisher","unstructured":"Murarka S, Movahed MR. Diabetic cardiomyopathy [published correction appears in J Card Fail. 2011 Mar;17(3):264]. J Card Fail. 2010;16(12):971\u2013979. doi:https:\/\/doi.org\/10.1016\/j.cardfail.2010.07.249","DOI":"10.1016\/j.cardfail.2010.07.249"},{"issue":"1\u20132","key":"1885_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000064682","volume":"98","author":"CM Schannwell","year":"2002","unstructured":"Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98(1\u20132):33\u20139. https:\/\/doi.org\/10.1159\/000064682","journal-title":"Cardiology"},{"issue":"21","key":"1885_CR18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/eurheartj\/ehy625","volume":"40","author":"Y Wasserstrum","year":"2019","unstructured":"Wasserstrum Y, Barriales-Villa R, Fern\u00e1ndez-Fern\u00e1ndez X, et al. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy. Eur Heart J. 2019;40(21):1671\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehy625","journal-title":"Eur Heart J"},{"issue":"2","key":"1885_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/675994","volume":"4","author":"L Benson","year":"2014","unstructured":"Benson L, Brittain EL, Pugh ME, et al. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Pulm Circ. 2014;4(2):311\u20138. https:\/\/doi.org\/10.1086\/675994","journal-title":"Pulm Circ"},{"issue":"1","key":"1885_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.20452\/pamw.15103","volume":"130","author":"K Jonas","year":"2020","unstructured":"Jonas K, Kope\u0107 G. A challenging phenotype of pulmonary arterial hypertension. Pol Arch Intern Med. 2020;130(1):85\u20136. https:\/\/doi.org\/10.20452\/pamw.15103","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"1885_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1086\/679705","volume":"5","author":"AD Abernethy","year":"2015","unstructured":"Abernethy AD, Stackhouse K, Hart S, et al. Impact of diabetes in patients with pulmonary hypertension. Pulm Circ. 2015;5(1):117\u201323. https:\/\/doi.org\/10.1086\/679705","journal-title":"Pulm Circ"},{"issue":"3","key":"1885_CR22","doi-asserted-by":"publisher","first-page":"1800279","DOI":"10.1183\/13993003.00279-2018","volume":"51","author":"A Boucly","year":"2018","unstructured":"Boucly A, Weatherald J, Humbert M, Sitbon O. Risk assessment in pulmonary arterial hypertension. Eur Respir J. 2018;51(3):1800279. https:\/\/doi.org\/10.1183\/13993003.00279-2018. Published 2018 Mar 29.","journal-title":"Eur Respir J"},{"key":"1885_CR23","doi-asserted-by":"publisher","unstructured":"Rosenkranz S, Pausch C, Coghlan JG, et al. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: a COMPERA analysis. J Heart Lung Transplant. 2023 Jan;42(1):102\u201314. https:\/\/doi.org\/10.1016\/j.healun.2022.10.003. Epub 2022 Oct 13.","DOI":"10.1016\/j.healun.2022.10.003"},{"key":"1885_CR24","doi-asserted-by":"publisher","unstructured":"Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010 Feb;137(2):376\u201387. https:\/\/doi.org\/10.1378\/chest.09-1140. Epub 2009 Oct 16.","DOI":"10.1378\/chest.09-1140"},{"issue":"47","key":"1885_CR25","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","volume":"39","author":"D Kylhammar","year":"2018","unstructured":"Kylhammar D, Kjellstr\u00f6m B, Hjalmarsson C, et al. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. 2018;39(47):4175\u201381. https:\/\/doi.org\/10.1093\/eurheartj\/ehx257","journal-title":"Eur Heart J"},{"issue":"10","key":"1885_CR26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/CIRCULATIONAHA.106.663120","volume":"115","author":"G Hansmann","year":"2007","unstructured":"Hansmann G, Wagner RA, Schellong S, et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007;115(10):1275\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.663120","journal-title":"Circulation"},{"issue":"1","key":"1885_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165\u201375. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301141","journal-title":"Circ Res"},{"issue":"9","key":"1885_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","volume":"122","author":"E Soon","year":"2010","unstructured":"Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122(9):920\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933762","journal-title":"Circulation"},{"issue":"5","key":"1885_CR29","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","volume":"151","author":"M Humbert","year":"1995","unstructured":"Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;151(5):1628\u201331. https:\/\/doi.org\/10.1164\/ajrccm.151.5.7735624","journal-title":"Am J Respir Crit Care Med"},{"key":"1885_CR30","doi-asserted-by":"publisher","unstructured":"Jonas K, Mago\u0144 W, Podolec P, Kope\u0107 G. Triglyceride-to-high-density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension. Med Sci Monit 2019 Jan 26;25:746\u201353. doi: https:\/\/doi.org\/10.12659\/MSM.912766. PMID: 30683836; PMCID: PMC6359883.","DOI":"10.12659\/MSM.912766"},{"key":"1885_CR31","doi-asserted-by":"publisher","unstructured":"Jonas K, Kope\u0107 G. HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension. Int J Mol Sci. 2019;20(14):3514. Published 2019 Jul 18. doi:https:\/\/doi.org\/10.3390\/ijms20143514","DOI":"10.3390\/ijms20143514"},{"issue":"14","key":"1885_CR32","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.114.013878","volume":"131","author":"JW Barnes","year":"2015","unstructured":"Barnes JW, Tian L, Heresi GA, et al. O-linked \u03b2-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension. Circulation. 2015;131(14):1260\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013878","journal-title":"Circulation"},{"key":"1885_CR33","doi-asserted-by":"publisher","unstructured":"Hoeper MM, Dwivedi K, Pausch C, et al. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis. Lancet Respir Med. 2022 Oct;10(10):937\u201348. https:\/\/doi.org\/10.1016\/S2213-2600(22)00097-2. Epub 2022 Jun 28.","DOI":"10.1016\/S2213-2600(22)00097-2"},{"key":"1885_CR34","doi-asserted-by":"publisher","unstructured":"Tonelli AR, Plana JC, Heresi GA, Dweik RA. Prevalence and prognostic value of left ventricular diastolic dysfunction in idiopathic and heritable pulmonary arterial hypertension. Chest. 2012 Jun;141(6):1457\u201365. https:\/\/doi.org\/10.1378\/chest.11-1903","DOI":"10.1378\/chest.11-1903"},{"key":"1885_CR35","doi-asserted-by":"publisher","unstructured":"Farber HW, Miller DP, Poms AD, et al. Five-year outcomes of patients enrolled in the REVEAL Registry. Chest. 2015 Oct;148(4):1043\u201354. https:\/\/doi.org\/10.1378\/chest.15-0300","DOI":"10.1378\/chest.15-0300"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01885-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01885-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01885-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T16:04:42Z","timestamp":1689264282000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01885-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01885-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of the study was reviewed and accepted by the local Bioethical Committee (OIL\/KBL\/27\/2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}